About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT03195868

Photobiomodulation Therapy and Nerve Density for Patients With Diabetic or Chemotherapy-associated Neuropathy

This study seeks to determine if photobiomodulation (PBM, or low level laser light) affects the growth and distribution of nerves int he skin. Our previous study demonstrated that the treatment we use...

Lead sponsor: University of Minnesota•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Minnesota

Consenting patients with self-reported neuropathy following either diabetes or administration of chemotherapy, will undergo sensory testing and skin biopsies of the the foot and leg prior to initiating treatment. They will undergo PBM 3 times weekly for 6 weeks with with a follow-up biopsy performed at the conclusion of therapy and sensory testing throughout. Patients will have one remote evaluation at 26 weeks to determine whether the effect, if any extinguishes.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•willingness to undergo biopsies and 6 weeks of therapy

Exclusion Criteria

•pregnancy
•active cancer treatment

Related studies

Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy

NCT06389721 · Chemotherapy-induced Peripheral Neuropathy

Feasibility and Clinical Utility of Paired Non-Invasive Hemodynamic and Tissue Oximetry Monitoring to Detect Limb Ischemia in Lithotomy-Positioned Surgeries

NCT07387653 · Neuropathy;Peripheral, Limb Ischemia

Plantar Intrinsic Muscles Exercises and Three-dimensional Ankle Foot Exercises Comparative Effect in DPN

NCT07576179 · Diabetic Peripheral Neuropathy (DPN)

RECRUITINGPhase 3

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT06290141 · Chronic Inflammatory Demyelinating Polyneuropathy

RECRUITINGPhase 4

Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes

NCT07558863 · Type 2 Diabetes, Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 9, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment70

Start dateSep 2019

Last updatedJun 9, 2022

Condition

Neuropathy Neuropathy, Diabetic Neuropathy Toxic

Locations shown

University of Minnesota

Minneapolis, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 9, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions